Ding L, Wang Q, Martincuks A, et al. STING agonism overcomes STAT3-mediated immunosuppression and adaptive resistance to PARP inhibition in ovarian cancer. Journal for immunotherapy of cancer. 2023;11(1). doi:10.1136/jitc-2022-005627
Publications
Vlasschaert C, Heimlich B, Rauh MJ, Natarajan P, Bick AG. Interleukin-6 Receptor Polymorphism Attenuates Clonal Hematopoiesis-Mediated Coronary Artery Disease Risk Among 451 180 Individuals in the UK Biobank. Circulation. 2023;147(4):358-360. doi:10.1161/CIRCULATIONAHA.122.062126
Li Q, Agrawal R, Schmitz-Abe K, et al. Reanalysis of clinical exome identifies the second variant in two individuals with recessive disorders. European journal of human genetics : EJHG. 2023. doi:10.1038/s41431-023-01291-2
Lingaas F, Tengvall K, Jansen JH, et al. Bayesian mixed model analysis uncovered 21 risk loci for chronic kidney disease in boxer dogs. PLoS genetics. 2023;19(1):e1010599. doi:10.1371/journal.pgen.1010599
Tan J, Shenker-Tauris N, Rodriguez-Hernaez J, et al. Cell-type-specific prediction of 3D chromatin organization enables high-throughput in silico genetic screening. Nature biotechnology. 2023. doi:10.1038/s41587-022-01612-8
Rajagopal VM, Ganna A, Coleman JRI, et al. Genome-wide association study of school grades identifies genetic overlap between language ability, psychopathology and creativity. Scientific reports. 2023;13(1):429. doi:10.1038/s41598-022-26845-0
Parry EM, Leshchiner I, Guièze R, et al. Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome. Nature medicine. 2023;29(1):158-169. doi:10.1038/s41591-022-02113-6
Stein MB, Jain S, Parodi L, et al. Polygenic risk for mental disorders as predictors of posttraumatic stress disorder after mild traumatic brain injury. Translational psychiatry. 2023;13(1):24. doi:10.1038/s41398-023-02313-9
Wang Y, Fan JL, Melms JC, et al. Multimodal single-cell and whole-genome sequencing of small, frozen clinical specimens. Nature genetics. 2023;55(1):19-25. doi:10.1038/s41588-022-01268-9
Aquilanti E, Kageler L, Watson J, et al. Telomerase inhibition is an effective therapeutic strategy in TERT promoter mutant-glioblastoma models with low tumor volume. Neuro-oncology. 2023. doi:10.1093/neuonc/noad024